TP53 and non-small cell lung carcinoma: To elucidate the role of these pathways in the tumorigenesis of NSCLC, we have determined the protein expression levels of key players in NSCLC, including EGFR, pAKT, pERK, and p53, as prognostic biomarkers in early-stage NSCLC.